项目 发表于 2025-3-25 07:16:43

http://reply.papertrans.cn/2/185/18439/18439-21.png

recede 发表于 2025-3-25 08:14:36

Submitted on: 17 February 2007.
Revised on: 28 May 2007.
Accepted on: 11 June 2007.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

厨师 发表于 2025-3-25 15:10:52

Submitted on: 27 April 2020.
Revised on: 03 August 2020.
Accepted on: 07 September 2020.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Brochure 发表于 2025-3-25 17:58:21

http://reply.papertrans.cn/2/185/18439/18439-24.png

Postulate 发表于 2025-3-25 20:04:12

Submitted on: 12 June 1999.
Revised on: 11 September 1999.
Accepted on: 12 October 1999.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

CRAFT 发表于 2025-3-26 02:20:39

http://reply.papertrans.cn/2/185/18439/18439-26.png

毗邻 发表于 2025-3-26 05:39:14

http://reply.papertrans.cn/2/185/18439/18439-27.png

glisten 发表于 2025-3-26 12:19:12

http://reply.papertrans.cn/2/185/18439/18439-28.png

prolate 发表于 2025-3-26 15:26:18

Submitted on: 04 November 2002.
Revised on: 12 February 2003.
Accepted on: 25 February 2003.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

鞭打 发表于 2025-3-26 19:37:35

http://reply.papertrans.cn/2/185/18439/18439-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:1.963 (J OCUL PHARMACOL TH) (1080-7683). (OPHTHALMO